POC - Technology change not the issue, rather how products are marketed
This article was originally published in Clinica
Executive Summary
We are wont to say in this new millennium that in the wake of major disasters - man-made or natural - the world is changed forever. No one can be sure. But closer to home, in our own domain, we can be sure that molecular medicine and genomics have changed the world of diagnostics. The problem is that too few in the industry are changing their business models accordingly, preferring to hang out their "business as usual" signs on the corporate door, writes Peter Keeling*.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.